Non-small cell lung cancer: an overview of current management

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
J Dancey, T Le Chevalier

Abstract

Non-small cell lung cancer (NSCLC) will remain a worldwide health problem for the foreseeable future. Unfortunately, local treatment of this disease is disappointing as most patients develop uncontrollable locally advanced or distant metastatic disease. The recent meta-analysis using updated patient data has suggested a potential role for adjuvant cisplatin-based chemotherapy (CT) in early stage disease, and has shown a significant, albeit modest, improvement in survival when combined with radiotherapy in locally advanced disease and as a single modality in metastatic disease. Although quality and cost of extra life with this more aggressive treatment need to be defined in prospective studies, CT should be considered standard treatment for patients with locally advanced and metastatic NSCLC able to receive cisplatin-based CT. Its role in stage I and II disease is under current investigation. Ongoing clinical studies with more active agents, novel combined modality treatment strategies and laboratory discoveries continue to emerge which may lead to valuable new treatment options to extend this survival advantage.

References

Feb 20, 1992·The New England Journal of Medicine·C Schaake-KoningA Nijs
Apr 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R L BurkesJ D Cooper
Jun 1, 1992·The Annals of Thoracic Surgery·H I PassJ Minna
Oct 1, 1992·British Journal of Cancer·R McLarenK C Gatter
Jan 1, 1992·American Journal of Industrial Medicine·E WardK Steenland
Aug 1, 1991·Controlled Clinical Trials·S J Pocock
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A T van Holten-VerzantvoortF J Cleton
Aug 30, 1990·The New England Journal of Medicine·R J SlebosW J Mooi
Nov 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D OsobaF A Shepherd
Jan 1, 1989·Acta Oncologica·C FernandezM Roviralta
Oct 27, 1989·Science·T TakahashiJ D Minna
Mar 1, 1988·European Journal of Cancer & Clinical Oncology·K MattsonE Nordman
Jul 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L H EinhornW Fisher
Jan 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J C RuckdeschelS Vogl
Jan 1, 1981·Journal of Chronic Diseases·W O SpitzerB R Catchlove
Jun 16, 1993·Journal of the National Cancer Institute·A GregorH H Hansen
May 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G M StraussD J Sugarbaker
Mar 1, 1995·Current Opinion in Oncology·B Bergman, N K Aaronson
Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F V FossellaB Glisson
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P A FrancisR T Heelan
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F V FossellaS Benner
Mar 1, 1994·Current Opinion in Oncology·G M Petersen
Aug 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R P AbrattT A Rugg
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B BergmanM Sullivan
Sep 1, 1994·Chest·E E Vokes, J D Bitran
Sep 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M B HazukaR B Livingston
Sep 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H AndersonH H Hansen
Oct 5, 1994·Journal of the National Cancer Institute·D P Carbone, J D Minna
Oct 5, 1994·Journal of the National Cancer Institute·T FujiwaraJ A Roth
Mar 3, 1993·Journal of the National Cancer Institute·W K MurphyM N Raber
Feb 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T J LynchE Frei
Dec 1, 1993·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L CrinòM Tonato

❮ Previous
Next ❯

Citations

Dec 7, 2005·Journal of Cancer Research and Clinical Oncology·Yanguang GaoXianlu Zeng
Sep 15, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·S AgelakiA Raptis
Sep 15, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·N Rodríguez-SalasC Gamallo
Jun 12, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Robert ChinEdward F Haponik
Dec 25, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·D MavroudisV Georgoulias
Mar 1, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Filippo De MarinisUNKNOWN Foundation for Oncological Research
Mar 1, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Roy M BremnesUNKNOWN Norweigian Lung Cancer Study Group
Aug 21, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Petr ZatloukalMilan Kůta
Aug 10, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J Verweij, M J de Jonge
Apr 6, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L OrlandiN Zaffaroni
Jan 8, 2004·Seminars in Thoracic and Cardiovascular Surgery·Richard F Riedel, Jeffrey Crawford
Mar 14, 2003·Seminars in Oncology·Jyoti D PatelVincent A Miller
Mar 25, 2016·Fundamental & Clinical Pharmacology·Xuefeng JiaJunbo Jiao
Oct 27, 2015·Biochemical and Biophysical Research Communications·Fan XieJingping Ma
Jun 24, 2004·Canadian Journal of Physiology and Pharmacology·Beata KosmiderJustyn Ochocki
Jan 7, 2004·Clinical Lung Cancer·Eelco FokkemaElisabeth G E de Vries

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
K Østerlind
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
D Ferrigno, G Buccheri
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
B Passlick
© 2021 Meta ULC. All rights reserved